Echinometra lucunter is an abundant sea urchin found in Brazilian waters. Accidents caused by this animal are common and are characterized by the penetration of the spines in the skin, which raises an inflammatory reaction through mechanical trauma as well as by the presumable action of toxins. Additionally, there have been reports of inflammatory reaction after the consumption of raw sea urchin eggs. In this work, we have isolated a peptide from E. lucunter coelomic fluid that could elicit inflammatory reactions, such as paw edema, leukocyte recruitment and diminishment of the pain threshold. This peptide was termed Echinometrin. Moreover, the peptide administration was able to produce in vivo degranulation of mouse mast cells, in a dose-response manner. The peptide was 'de novo' sequenced by mass spectrometry and its synthetic analog could reproduce all the observed effects. Sequence alignment indicates that this peptide is comprised in vitellogenin, an abundant nutrient protein present in the gametogenic cells of sea urchins, making it possible that echinometrin would be a cryptide with pro-inflammatory effects.
Introduction
Echinometra lucunter (Echinodermata: Echinoidea) is an edible wide-spread species, commonly found in tropical and subtropical shallow waters, such as tide pools and reef slopes [25] in the Western Central Atlantic, ranging from the USA throughout the Caribbean, and along most of the Brazilian shores, where it is the most abundant sea urchin species. It feeds on plants [34] and is generally found in holes in the substrate of shallow rocky areas on reefs, particularly in locations of surf and wave surge. This species erodes cavities or burrows in rock to create a protective chamber [1] . The pharmacological (pro-inflammatory) and initial biochemical features of the spines extracts of this species have already been evaluated by our group [45, 46] , once this urchin is responsible for the majority of the sea animal accidents reported in the Brazilian coastal medical facilities [22] .
reports of gastrointestinal inflammatory reactions after the consumption of such food [12, 16] .
Inflammation is a process to repair injured tissues, characterized by cellular, vascular and biochemical alterations. The process is divided into two phases: acute and chronic, differentiated by the type of cells and inflammatory mediators released [30] . When there is an injury, cells are activated and the mediators are released. One of these cells is mast cells [20] .
Mast cells are located in a variety of tissues, such as intestinal and pulmonary epithelium, connective tissue and skin, associated with blood and lymphatic vessels and nerves [31] . They are key players on the inflammatory processes because is the first cells to initialize the inflammation [15, 40] . When these cells are activated, granules containing stored inflammatory mediators (such as vasoactive amines and neutral proteases) are exposed, a process known as mast cell degranulation. The activation is mediated by IgE and complement proteins [26] . However, it was described some molecules that are able to induce the degranulation, for instance 48/80, a polymer amine [27] and peptides, such as mastoparans, isolated from wasp venom [24] . Such molecules would serve as important biotechnology tools in the study of mechanism of action in allergy, inflammation, and even as an adjuvant vaccine [33] .
In this work we report the isolation, biochemical characterization and pharmacological properties of a novel octapeptide from the coelomic fluid of E. lucunter sea urchin, able to induce mast cell degranulation and evoke inflammatory effects. This peptide was termed echinometrin.
Materials and methods

Drugs and reagents
All the employed reagents were of analytical grade and were purchased from Sigma Co. (St. Louis, MO, USA), unless otherwise stated.
Animals
Male Swiss mice (20-25 g ) and male Wistar rats (180 g) were used throughout the study. All animals were treated and maintained under ethical conditions, at animal housing facilities of Instituto Butantan, approved by the Institutional Animal Care Committee of the Butantan Institute (CEUAIB, protocol number 438/07).
Sea urchins and coelomic fluid collection and sample preparation
Specimens of E. lucunter were collected in São Sebastião, SP, Brazil (23 • 49 53 S; 45 • 31 18 W), under license number (13852-1) from the Brazilian Environmental Agency (IBAMA-Instituto Brasileiro do Meio Ambiente e dos Recursos Naturais Renováveis). Animals were collected without distinction of sex, age or size. The coelomic fluid was extracted from the sea urchin by puncturing the peristomial membrane, being approximately 30 mL by animal. Right after collection, the fluid was added to acetic acid 0.05% (v:v; final concentration) or protease inhibitor cocktail (Roche Applied Science, Complete, Cat No. 04 693 124 001), to prevent protein and peptide hydrolysis, and was kept in ice bath until further processing. The coelomic fluid was then centrifuged at 1248 × g for 5 min, at 4 • C and the supernatant was processed by solid phase extraction (SPE) using C18 cartridges (Strata ® , 55 m, 70Å, 5 g/20 mL, Phenomenex Inc., Torrance, CA, USA) and elution with 25% acetonitrile (ACN), containing 0.1% trifluoroacetic acid (TFA).
Chromatographic steps
The 25% ACN SPE-fraction was purified by reversed phase high performance liquid chromatography (RP-HPLC) using a binary HPLC system (20A Prominence, Shimadzu Co., Japan). Aliquots of the samples were loaded in a C18 column (ACE C18, 5 m, 100Å, 250 mm × 7.75 mm) in a two-solvent system: (A) TFA/H 2 O (1:1000) and (B) TFA/Methanol/H 2 O (1:900:100). The content was eluted at a constant flow rate of 1.7 mL min −1 with a 0-100% gradient of solvent B over 35 min, after a 5 min isocratic elution with 0% B. The HPLC column eluates were monitored by a Shimadzu SPD-M20A PDA detector scanning from 200 to 500 nm (1 nm steps) and the peak of interest was manually collected.
For sample purification, one additional chromatographic step was necessary, employing a C18 core-shell column (2.6 m, 100Å, 100 mm × 4.6 mm, Kinetex ® , Phenomenex Inc., USA), at a constant flow rate of 1.2 mL min −1 with a 0-100% gradient of solvent B (TFA/ACN/H 2 O; 1:900:100) over 20 min, after a 5 min isocratic elution with 0% B .
Mass spectrometry
Mass spectrometry analyses were performed in an ESI-ITTof mass spectrometer (Shimadzu Co., Japan). The sample was diluted in a 50% ACN containing 0.5% formic acid, and was directly introduced in the spectrometer using a Rheodyne 7010 sample loop, at a flow rate of 50 L min −1 , in positive ionization mode. The interface voltage was kept at 4.5 kV, the detector voltage at 1.76 kV and the capillary temperature at 200 • C. The instrument control and data acquisition was conducted by LCSolutions (Shimadzu Co., Japan), being the mass spectra collected in the 50-2000 m/z range. For the MS/MS analysis, argon collision energy was kept in 50% and the precursor ions were selected under a 0.5 m/z window. The results were automatically processed by Peaks 5.0 software (Bioinformatics Solution Inc.), and then manually verified. The Ile/Leu alternates were solved by amino acid analyses. Briefly, the sample was hydrolyzed with 1 M HCl (containing phenol) in a sealed ampoule, at 110 • C for 10 h. It was then dried and washed with H 2 O:ethanol:triethylamine (TEA) (2:2:1) prior to phenylthiohydantoin (PTH) derivatization (15 min) in ethanol:TEA:PTH:H 2 O (7:1:1:1). The reaction products were then analyzed by HPLC and compared to an 18 amino acid standard.
Peptide synthesis
Synthetic peptide was obtained in automated bench-top simultaneous multiple solid-phase synthesizer (PSSM 8 system from Shimadzu Co., Japan) using solid phase peptides synthesis by the Fmoc-Procedure [5] . The peptide was purified by reversed-phase chromatography (Shim-pack Prep-ODS, 5 m, 20 mm × 250 mm Shimadzu Co.) semi-preparative HPLC, and the purity and identity of the peptide was confirmed by ESI-IT-TOF mass spectrometry and by analytical HPLC, in the same conditions described above.
Intravital microscopy of cremaster venules
Leukocyte responses within mouse cremaster venules were assessed by intravital microscopy. Echinometrin (0.5 g/g animal, diluted in 100 L of sterile saline) or sterile saline (control) were injected in mice (n = 5), into the subcutaneous (s.c.) tissue of the scrotal bag. After 2 or 24 h, animals were anesthetized with injection (s.c.) of ketamine (100 mg/kg) and xylazine (10 mg/kg) and the cremaster muscle was exteriorized for microscopic examination in situ as previously described by Baez [6] . During the experimental procedure, mice were maintained on a special board thermostatically controlled at 37 • C, which included a transparent platform on which the cremaster was placed. Leukocyte responses were evaluated by light microscope (Axioplan II, Carl Zeiss, Germany), equipped with Achroplan objectives 10.0/0.25 (longitudinal distance/numeric aperture and 1.60 optovar). Images were captured by a video camera (JVC, Japan) and simultaneously transmitted to a TV monitor. Images were digitalized in the computer and analyzed by software (KS 300, Kontron, Carl Zeiss, Germany). One to three post-capillary venules were selected at random. After the stabilization period (initial 10 min), rolling and adhering leukocytes were counted during 3 min in a 100-mm vascular segment. Firmly adherent leukocytes were considered those cells remaining stationary for at least 30 s within a given 100-mm vessel segment. Transmigrated leukocytes were quantified as those in the extravascular tissue within 50 mm of each side of the 100-mm vessel segments studied. Results were expressed as the difference (%) of volume between paws injected with sample and sterile saline, and compared to the results before the administration.
Evaluation of paw edema
Nociceptive threshold evaluation
Rats (n = 8) were evaluated by the paw pressure test before and at different times (1, 2 and 4 h) after intraplantar injection of echinometrin (10 g/paw). The pain threshold was measured using an Ugo Basile ® pressure apparatus, essentially as described elsewhere [41] . Briefly, a force of increasing magnitude (16 g/s) was applied to the paw. When the rat reacted by withdrawing the paw, the force (in g) required to induce this response represented the pain threshold. The hyperalgesic activity was expressed as the decrease in the force needed to induce the withdrawal response in treated rats compared with control rats that received only sterile saline.
Histological assessment of mesenteric mast cell (MC) degranulation
Echinometrin, dissolved in 500 L sterile physiological saline (0.05, 0.5 and 1 g/g animal) was injected by the intraperitoneal (ip.) route. Control animals received 500 L of sterile saline. At selected time intervals (10-60 min) after these injections, the animals were euthanized under halothane atmosphere and exsanguinated. The abdomen was opened and the mesentery was carefully removed for histological assessment of mast cell degranulation. Mesentery was placed in a 4% formaldehyde solution at 4 • C for 2 h, mounted on a glass slide and then stained with Giemsa. Mast cell degranulation was expressed as percentage of mast cells with extruded granules relative to the total mast cells present in the stained mesentery. At least 100 cells were counted per stained tissue. In rats, degranulated cells can be visualized once the granules remain stained even after discharge from cells [38] .
Hemolytic assay
The hemolytic assay was performed following the method described by Al-Badri et al. [2] , with some modifications. Fresh human blood was obtained from healthy donors and erythrocytes were separated by centrifuging whole blood (3000 rpm, 10 min), to remove plasma and white cells. One mL of red blood cells (RBC) were diluted with 9 mL of PBS buffer (10 mM phosphate buffer, pH 7 and 150 mM NaCl). The suspension was further diluted to give a RBC 4%. The sample, diluted in the assay buffer, was incubated with RBS 4% (20 L) and PBS buffer (50 L) at 37 • C for 1 h. The tube was centrifuged at 1240 × g for 5 min and 60 L of supernatant were transferred to 96-well plate, and the hemoglobin released was measured at 414 nm. Data were compared with negative control (100 L PBS buffer and 20 L RBC 4%) and a positive control (50 L PBS buffer, 50 L Triton X-100 0.1% and 20 L RBC 4%). Experiments were performed in triplicate. Percent hemolysis was calculated as follows: (%) = (A sample − A buffer )/(A triton − A buffer ) × 100.
Antimicrobial assay
Antimicrobial activity was monitored by a liquid growth inhibition assay against Micrococcus luteus A270, Escherichia coli SBS 363, Pseudomonas aeruginosa ATCC 14502 and Staphylococcus aureus ATCC 6538, as described by Bulet et al. [9] . Pre inocula of the strains were prepared in Poor Broth (PB) and incubated at 37 • C with shaking. The absorbance at 595 nm was determined and one aliquot of this solution was taken to obtain cells in logarithmic growth (A595 nm ∼0.6), and diluted 600 times (A595 nm = 0.0001). The fractions and pure peptides were dissolved in sterile Milli-Q water, at a final volume of 100 L (10 L of the peptide and 90 L of the inoculum in PB broth). After incubation for 18 h at 30 • C the inhibition of bacterial growth was determined by measuring absorbance at 595 nm.
Statistical and sequence analyses
Results are presented as mean ± standard error of mean. Statistical evaluation of data was carried out by Student's t test, one-way ANOVA followed by Tukey's post-test or repeated measures twoway ANOVA followed by Bonferroni post-test (GraphPad Prism 5, GraphPad Software Inc, USA). Differences of results were considered statistically significant when p < 0.05.
Peptide sequence analyses was performed by using the NCBI BLAST server, BLASTP 2.2.28 Program and the nr database (All nonredundant GenBank CDS translations + PDB + SwissProt + PIR + PRF excluding environmental samples from WGS projects) restricting or not the organisms to sea urchins (taxid:7625), according to [3] for blastp and according to [3, 8, 44] in the case of DELTA-BLAST. Multiple sequence alignment was performed by ClustalW2, with default parameters [29] .
Results
Purification and biochemical characterization
The 25% ACN SPE fraction was analyzed RP-HPLC (Fig. 1A ) and peaks were manually collected and tested for MC degranulation and pro-inflammatory effects, being one peak positive in the assays (arrow). Since more than one molecule were found in the peak of interest (data not shown), one additional chromatographic step was necessary to purify the molecule. Biological assay monitoring indicated that the active molecule was present in the peak indicated by the arrow, in Fig. 1B . Each 30 mL of coelomic fluid processed, about 400 g of the interested peptide was obtained.
Mass spectrometry analyses of the active peak indicated the presence of a possible peptide ( Fig. 2; m/ (Fig. 3A) and the daughter ions allowed the de novo sequence of a peptide. Spectra were analyzed by PEAKS (Demo version) and manually checked for accuracy and precision. The deduced sequence of the peptide was LRKLMLQR. The presence of leucine instead of isoleucine could be confirmed by amino acid analysis (supplemental material). The peptide was termed echinometrin, in allusion to the animal genus.
A synthetic echinometrin analog was obtained by solid phase peptide synthesis and analyzed by mass spectrometry (MS and MS/MS), in order to confirm the homology with the natural peptide. Fig. 3B presents the dissociation of the [M+2H] 2+ ion of the synthetic peptide. It is possible to note the spectra are virtually identical in the fragmentation pattern, in the measured mass of the ions and in the relative intensity of the peaks.
The amino acid sequence of echinometrin was submitted to DELTA-BLAST analyses [3, 8, 44] against the nr database. The forth blast hit, out of the 100 best protein hits, was a continuous region from a predicted uncharacterized protein from Strongylocentrotus purpuratus sea urchin [LOC583660 Strongylocentrotus purpuratus Sequence ID: ref|XP 003726745.1|], . . .EG 367 LRKLMLER 374 FM. . ., with a conservative Glu/Gln substitution at the 7th amino acid (echinometrin numbering). Also, presenting a lower score, there was a blast hit with flagellar creatine kinase (P18294) of S. purpuratus (. . .QI 726 LRALRLQK 733 RG. . .). The aligned sequences are presented in Table 1 , which also contains the corresponding region of the only vitellogenin with 3D structure, isolated from the silver lamprey. The full alignment of the two viltellogenins is presented on the supplemental material, which also contains the 3D structure of the lamprey vitellogenin, showing (in red) the region that contains the echinometrin related peptide. Noteworthy, this region is exposed and accessible to proteolysis.
Echinometrin ----------------LR KLM L QR -----------------8
H3I5S1(1015-1055) MGF S LN P LE V GF K VE GLR KLM L ER F -MS NS E SG DGD N RDR L 40
P18294(710-745) VKL P LL S KY P RF D -Q ILR ALR L QK R GT G GV D TA STD G TFD I 40
Q91062(666-706) MGY A SD I VE F GL R AE G LQ ELL Y RG S -QE QD
Pro-inflammatory effects
Echinometrin was able to induce alterations in the mouse microcirculation, with recruitment of leukocytes in the area of peptide injection, the cremaster muscle. After 2 h of injection, a diminishment of rolling cells and an increase of adhered and migrated cells could be observed (Fig. 4A) . After 24 h, rolling and adhesion cells returned to the basal levels, although migrated cells were still present (Fig. 4A) .
In order to evaluate the hypernociceptive effects, rats were submitted to paw pressure test. Initially, all animals presented the same pain threshold. One hour after 10 g/paw of echinometrin injection, the pain threshold significantly diminished, in comparison to the control group (Fig. 4B) . After 2, the diminishment of the pain threshold was still presented and only 4 h after echinometrin administration, the pain threshold value returned to the initial values.
Echinometrin also induced a dose-dependent paw edema, which reaches values of 64% with 20 g/paw and 42% with 10 g/paw (Fig. 4C) . The maximum edema value was obtained 15 min after injection, and was decreasing slowly.
The synthetic peptide was also assayed in mouse paw edema test, in the same concentration as the natural peptide (10 g), as performed before. The synthetic peptide reproduced the effects observed by natural peptide in this model of inflammation, as shown in Fig. 4D. 
Mast cell degranulation
As depicted in Fig. 5A , echinometrin (0.5 g/g mouse) was able to induce the MC degranulation after 30 min of administration. Spread granules around the MC were observed by light microscopy, being considered degranulated. The degranulation started 10 min after the peptide injection and progressively increased, until 30 min (Fig. 5B) . In 60 min after injection, no degranulated cells were observed. This effect occurred in a concentration-response manner, as showed in Fig. 5C , in 30 min after injection.
Hemolysis/antibacterial effect
Echinometrin was not able to induce hemolysis in human erythrocytes. Moreover, the peptide was not antibacterial, once did not cause lysis of bacteria, for the four tested strains (data not shown).
Discussion
In this work we report the isolation and biochemical characterization of echinometrin, a peptide/cryptide isolated from the peristomial coelomic fluid of E. lucunter sea urchin, which was able to initiate an inflammatory response in mammals, due to (at least in part) its capacity to degranulate mast cells (MCs).
MCs are known to be essential for the resolution of bacterial infections through neutrophil mobilization to the site of infection. These cells seem to coordinately initiate innate immune response (immune cell migration), believed to be essential in stimulating the adaptive immune response. These functions are believed to be due to the capacity of MCs to rapidly release prestored inflammatory mediators within few minutes after activation [33] , what contribute to rapid effects. Moreover, MCs are present in tissues that are in the first contact with the antigen (e.g. connective tissue) being the first cells to act when the tissue is injured [28] . The rapid effect observed after echinometrin injection is probably due to the participation of MCs: the studied tissue was mesentery (the first contact with the toxin, injected by intraperitoneal route) and the pre-stored mediators in MCs contribute to a rapid effect. Considering the inflammation as a multi-mediated process, the activation of MCs can release other mediators that prolong the inflammation, once we observed a decrease of pain threshold 2 h after echinometrin injection.
MC degranulation (MCD) may occur either by the activation of G protein, or through mast cell membrane lysis or even by both processes simultaneously [49] . When activated, MC release histamine and other inflammatory mediators, including proteases such as tryptase and chymase, lipid mediators (prostaglandins and leukotrienes) and cytokins [36] . These cells exhibit many active molecules on their surface that enable the cells to react to both IgE and non-IgE-related stimuli and to release mediators, resulting in an attraction of inflammatory cells. The high affinity of MCD peptide for mast cells makes it a suitable substance for studying allergic and inflammatory processes [10, 40] .
Peptides causing degranulation of MC have already been described in bee and wasp venoms [7, 23, 35, 36, 48] . Depending on the doses, they can cause both inflammatory and antiinflammatory activity [10] . Moreover, these peptides are thought to be involved in allergic and inflammatory processes related to type I hypersensitivity reaction that is caused by mast cell degranulation and subsequent release of histamine and other inflammatory mediators [23] . The mechanism of action is the interaction of the peptide with G-protein coupled receptors (GPCR), activating different types of basophils and chemotaxis of leukocytes. On the other hand, some peptides present ␣-helical conformations depending on the environment, being an amphipathic structure, which favors electrostatic interactions with the negatively charged biological membranes, which may lead to peptide insertion into the membrane bilayer and consequent lysis of the cell [7, 36] . Thus, these peptides are hemolytic and/or antimicrobian [35, 48] .
In the case of echinometrin, the suggested mechanism is the entry in the MCs and activation of G protein, once this peptide has no effect on lysis of membranes (it is not hemolytic and antimicrobial) [11] . The observed pro-inflammatory effects, such as leukocyte recruitment, paw edema and hypernociception, probably occurred due to the release of mediators from MCs. During the inflammation process, the cell recruitment is caused by the presence of chemotactic mediators, such as histamine, bradykinin, prostaglandin, etc. The action of mediators induce hemostatic alterations (causing edema) and leukocyte migration, by expression of adhesion molecules on leukocytes (selectins and integrins), that cause leukocyte-endothelium interaction [18, 37] .
Yamasaki et al. [51] identified a 152 kDa allergen from sea urchin roes -the major yolk protein (MYP) -that was able to increase the serum concentration of IgE. Moreover, Rodriguez et al. [43] identified a 118 kDa protein from the urchin roes that mediated allergy by IgE, as well. Echinometrin, on the other hand, possess a clearly different mechanism of action that includes no Ig involvement, once one single peptide dose was enough to raise the pharmacological effects, whereas the raising of IgE levels require at least two antigen administrations [32] .
MYP is abundant in sea urchin coelomic fluid, and is also a fragment of vitellogenin, another abundant protein in both male and female sea urchin individuals. Vitellogenin is incorporated into nutritive phagocytes, as a temporary stock, and is transported to the oocytes, to be accumulated as MYP, as a source of nutrients to gametogenesis [13, 50] .
BLAST analyses of echinometrin indicates it posses high homology with an internal sequence of the S. purpuratus uncharacterized gene product of LOC583660, with only a Gln/Glu substitution (Table 1) . Annotations on this entry reports a von Willebrand type D domain (VWD) besides a domain of unknown function (DUF). Data mining on these data showed that LOC583660 is also deposited in an alternate assembly of S. purpuratus genome as NW 001467127. This entry, however, is differently annotated, marking this protein as "similar to vitellogenin fused with superoxide dismutase" and also "similar to Sperm-activating peptides precursor". Finally, this sequence is also present in UNIPROT, under accession H3I5S1, in which it seems to have compiled all these annotations and consolidated them under a single entry. The similarities annotated in this entry are being similar to VWD and to DUF, but also to lipid transport activity and vitellogenin.
According to our interpretation, echinometrin would be a proteolytically generated internal fragment of E. lucunter vitellogenin (being the Glu/Gln substitution a species characteristic); therefore, it would be a cryptide. Briefly, cryptides are bioactive peptides generated by the proteolyses of non-classical precursor proteins that displays a biological function that normally is unrelated to the original protein function [39] . Our hypothesis is that the E. lucunter sea urchin vitellogenin, a nutrient protein source, would be enzymatically cleaved releasing -among others -echinometrin, a peptide able to degranulate mast cells and develop an inflammatory reaction. These rather different biological roles (nourishment × degranulation) would characterize the cryptic function of echinometrin. Considering that the vitellogenin is in contact with the sea urchin eggs, and echinometrin, a peptide secreted to the coelomic fluid, is also in contact with the eggs, this could be a possible explanation for the reported allergenic responses after the raw consumption of this animal.
Moreover, according to the deduced sequence of the possible precursor (H3I5S1), the release of echinometrin does not follow classical proteolytic processing sites, and would thus require two or more enzymes for the peptide processing. On the other hand, echinometrin may also be a creatine kinase derived cryptide. Our blast analyses point out this possibility, at a lower score position. However, one must take into account that sequences are being compared to S. purpuratus genome, due to the lack of information on E. lucunter genome/proteome. This piece of information is noteworthy to mention, due to the fact that our group has previously identified another marine animal vasoactive cryptide derived from creatine kinase, orpotrin [14] . In that occasion we have postulated that, besides trypsin-like serine peptidases, a cysteine peptidase, cathepsin L, would be able to cleave (according to the known subsite specificity [Merops -the peptidase database; 42]), creatine kinase and release orpotrin. In our investigations on E. lucunter biochemical and pharmacological features, we have describe a Cathepsin B/X like activity [45] that, perhaps, could be responsible for creatine kinase degradation with consequent release of echinometrin, making creatine kinase a multifunctional protein, similar to Lactoferrin [47] . Cathepsin B can cleave after glycine and Arginine residues and a glycine residue precedes echinometrin and arginine is the last amino acid of the peptide, when one considers creatine kinase amino acid sequence.
In conclusion, taking into account that major yolk protein has already been described as an anaphylactic reaction agent [51] , and that is passive of being cleaved by cathepsin B [52] , an enzyme previously described for E. lucunter, we describe in this work echinometrin, a cryptide derived from a putative vitellogenin that is able to cause inflammation probably by mast cell degranulation.
